The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

But there were also invisible treasures—assets you couldn’t touch but which added immense value to businesses. These were things like patents, copyrights, brand value, or software. Businesses ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

Our mostly-analog editor reflects on one of the major sustainability impacts of his career as a result of revolutionizing the ...

I liked reading the always-excellent Rob Greenspoon's post about five (almost) instant fixes to the patent system. The next U ...

The packaging machine supplier has developed a new drivetrain technology to boost productivity, energy efficiency.

From fundamental concepts to groundbreaking advancements, AI's integration into FinTech has transformed how businesses ...

The Madhya Pradesh government has formulated a new drone policy to foster manufacturing of drones in the state as well as ...

Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.

The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for six others. While this is expected to ...